Namibia - English - Namibia Medicines Regulatory Council

msd (pty) ltd - betamethasone disodium phosphate, betamethasone acetate - suspension - betamethasone disodium phosphate (solution) 3.0mg and betamethasone acetate (suspension) 3.0mg /ml

Namibia - English - Namibia Medicines Regulatory Council

msd (pty) ltd - betamethasone - syrup - betamethasone 0.6mg/5ml

Canada - English - Health Canada

sandoz canada incorporated - betamethasone acetate; betamethasone (betamethasone 21-disodium phosphate) - suspension - 3mg; 3mg - betamethasone acetate 3mg; betamethasone (betamethasone 21-disodium phosphate) 3mg - adrenals

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; phosphoric acid; monobasic sodium phosphate dihydrate; cetomacrogol 1000; sodium hydroxide; white soft paraffin - antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritis, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, statis dermatitis and psoriasis. indications as at 16 august 1999: antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis